Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
Skylar Luu, Haley S. Province, Elizabeth Berry‐Kravis, et al.
Brain Sciences (2020) Vol. 10, Iss. 9, pp. 629-629
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
Dragana Protić, Ramkumar Aishworiya, María Jimena Salcedo‐Arellano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1935-1935
Open Access | Times Cited: 60
Non-invasive cortical stimulation: Transcranial direct current stimulation (tDCS)
Pedro Sudbrack-Oliveira, Laís B. Razza, André R. Brunoni
International review of neurobiology (2021), pp. 1-22
Closed Access | Times Cited: 37
EEG as a translational biomarker and outcome measure in fragile X syndrome
Aisling Kenny, Damien Wright, Andrew C. Stanfield
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Brain Network Alterations in Fragile X Syndrome
Flavia Venetucci Gouveia, Jürgen Gernmann, George M. Ibrahim
Neuroscience & Biobehavioral Reviews (2025), pp. 106101-106101
Closed Access
Psychological Capital, College Adaptation, and Internet Addiction: An Analysis Based on Moderated Mediation Model
Xiangyang Bi, Jun Jin
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 24
Randomised controlled trials of mood stabilisers for people with autism spectrum disorder: systematic review and meta-analysis
Bharati Limbu, Shoumitro Deb, Meera Roy, et al.
BJPsych Open (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 17
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
Suma Jacob, Evdokia Anagnostou, Eric Hollander, et al.
Molecular Autism (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Effects of AFQ056 on language learning in fragile X syndrome
Elizabeth Berry‐Kravis, Leonard Abbeduto, Randi J. Hagerman, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 5
Open Access | Times Cited: 8
Current Perspectives on the Assessment and Management of Gait Disorders in Parkinson’s Disease
Matthew D. Smith, Danielle Pendry-Brazier, Emily J. Henderson
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2965-2985
Open Access | Times Cited: 19
Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
Christopher J. Keary, Lynne M. Bird, Marie‐Claire Y. de Wit, et al.
European Journal of Paediatric Neurology (2023) Vol. 47, pp. 6-12
Closed Access | Times Cited: 7
On the novel mechanisms for social memory and the emerging role of neurogenesis
Paula Lunardi, Lara M.Z. Mansk, Laura F. Jaimes, et al.
Brain Research Bulletin (2021) Vol. 171, pp. 56-66
Open Access | Times Cited: 15
Heterogeneity in Fragile X Syndrome Highlights the Need for Precision Medicine-Based Treatments
Edgard Verdura, Laura Pérez‐Cano, Rubén Sabido-Vera, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 13
Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
Dejan B. Budimirovic, Kelli C. Dominick, Lidia V. Gabis, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 13
Targeted Treatments for Fragile X Syndrome
Devon Johnson, Courtney Clark, Randi J. Hagerman
Advances in neurobiology (2023), pp. 225-253
Closed Access | Times Cited: 5
Do C-tactile afferents go to sleep? A potential role for somatosensory stimulation in sleep regulation
Martine Van Puyvelde, Olivier Maîresse
Current Opinion in Behavioral Sciences (2021) Vol. 43, pp. 62-68
Closed Access | Times Cited: 12
Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome
Walker S. McKinney, Lauren Schmitt, Lisa A. De Stefano, et al.
Journal of Child and Adolescent Psychopharmacology (2024)
Closed Access | Times Cited: 1
Identification of microRNAs associated with human fragile X syndrome using next-generation sequencing
Maryam Sotoudeh Anvari, Hamed Vasei, Hossein Najmabadi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities
Michelle L. Krishnan, Elizabeth Berry‐Kravis, Jamie K. Capal, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 653-654
Closed Access | Times Cited: 9
“Corp-Osa-Mente”, a Combined Psychosocial–Neuropsychological Intervention for Adolescents and Young Adults with Fragile X Syndrome: An Explorative Study
Federica Alice Maria Montanaro, Paolo Alfieri, Stefano Vicari
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 277-277
Open Access | Times Cited: 3
Toward an understanding of the role of the exposome on fragile X phenotypes
Cara J. Westmark
International review of neurobiology (2023), pp. 141-170
Closed Access | Times Cited: 3
Central Nervous System Trial Failures
Margaret C. Grabb, William Z. Potter
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 3, pp. 234-237
Open Access | Times Cited: 5
Five-Session Dual-Transcranial Direct Current Stimulation With Task-Specific Training Does Not Improve Gait and Lower Limb Performance Over Training Alone in Subacute Stroke: A Pilot Randomized Controlled Trial
Benchaporn Aneksan, Montawan Sawatdipan, Sunee Bovonsunthonchai, et al.
Neuromodulation Technology at the Neural Interface (2021) Vol. 25, Iss. 4, pp. 558-568
Closed Access | Times Cited: 7
Maternal Duplication 15q11-13 Syndrome with Autism Spectrum Disorder: Mood Stabilization by Carbamazepine
Christopher G. Viamontes, Jorge Castillo Gonzalez, Fedra Najjar, et al.
Journal of Child and Adolescent Psychopharmacology (2021) Vol. 32, Iss. 2, pp. 122-126
Closed Access | Times Cited: 6
Therapeutic potential of GABAA receptor subunit expression abnormalities in fragile X syndrome
Mathijs B. van der Lei, R. Frank Kooy
Expert Review of Precision Medicine and Drug Development (2022) Vol. 7, Iss. 1, pp. 105-120
Closed Access | Times Cited: 4
ExplantAnalyzer: An advanced automated neurite outgrowth analysis evaluated by means of organotypic auditory neuron explant cultures
Dominik Schmidbauer, Stefan Fink, Francis Rousset, et al.
Journal of Neuroscience Methods (2021) Vol. 363, pp. 109341-109341
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top